About
Stallergenes Greer is a global biopharmaceutical company specializing in the diagnosis and treatment of respiratory allergies through the development and commercialization of Allergy Immunotherapy products and services.
Our purpose is to enable people with allergies to live normal lives.
With more than 1,400 employees worldwide, a presence in 75 countries, and manufacturing facilities in both Europe and the United States, Stallergenes Greer plc is the parent company of GREER Laboratories, Inc. (whose registered office is in the U.S.) and Stallergenes S.A.S. (whose registered office is in France).
With complementary strengths, joint heritage and reputations, Stallergenes Greer is driving a continuing leadership in allergy immunotherapy.
- Company Name:Stallergenes Greer
(View Trends)
-
Headquarters: (View Map)London Wc1n, United Kingdom
-
Pharmaceuticals
-
1,000 - 5,000 employees
Site Traffic
- 2205502 Global Rank
- 174185 Poland
Traffic Sources
-
Search77.10%
-
Direct18.93%
-
Referrals3.19%
-
Social0.57%
-
Mail0.22%
-
Display0.00%
Powered by
![]()
Alexa Traffic Data
Global Rank
806,542
108,492
Links In Count
22
61
United Kingdom Rank
5,421
355,667
United Kingdom Page Views
78.0%
Top Countries
- United Kingdom 78.0%
- India 7.3%
- United States 5.4%
Top Sites Linking In
Top Search Keywords
- Los Angeles
They are headquartered at London Wc1n, United Kingdom, and have advertising & marketing contacts listed on Kochava. Stallergenes Greer works with Advertising technology companies such as DoubleClick.Net, FLoC Opt-Out, FLoC.
